Cargando…

Emerging dermatological and systemic applications of ustekinumab: beyond its clinical use in psoriasis

Detalles Bibliográficos
Autor principal:	Kapoor, Shailendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393119/ https://www.ncbi.nlm.nih.gov/pubmed/22791997 http://dx.doi.org/10.2147/CCID.S32149

Ejemplares similares

Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease
por: Kapoor, Shailendra
Publicado: (2012)

Emerging Anti Carcinogenic Applications of Nimesulide: Therapeutic Benefits Beyond Its Primary Role in Pain Management
por: Kapoor, Shailendra
Publicado: (2012)

Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab
por: Husein-ElAhmed, Husein, et al.
Publicado: (2013)

Propolis and it's emerging anti-neoplastic effects: beyond its role in oral dysplasia
por: Kapoor, Shailendra
Publicado: (2015)

Ustekinumab: differential use in psoriasis
por: Uhlenhake, Elizabeth E, et al.
Publicado: (2011)

Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Okita, Aline Lissa, et al.
Publicado: (2020)

Emerging treatments in the management of psoriasis: biological targeting with ustekinumab
por: Papoutsaki, Marina, et al.
Publicado: (2009)

Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab
por: Lambert, Jo, et al.
Publicado: (2021)

Erythrodermic Psoriasis Improved by Ustekinumab: A Report of Two Cases
por: Kim, Ye Seul, et al.
Publicado: (2016)

Testin and its emerging modulatory role in systemic carcinogenesis
por: Kapoor, Shailendra
Publicado: (2012)

The renoprotective effects of pentoxifylline: beyond its role in diabetic nephropathy
por: Kapoor, Shailendra
Publicado: (2013)

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis
por: Tsakok, Teresa, et al.
Publicado: (2019)

Ustekinumab in the therapy of chronic plaque psoriasis
por: O’Neill, Jenna L, et al.
Publicado: (2009)

Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
por: Savage, Laura J., et al.
Publicado: (2015)

Thyrotoxicosis Associated with Ustekinumab Treatment for Psoriasis
por: Olabi, Bayanne, et al.
Publicado: (2020)

Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis
por: Krulig, Eliana, et al.
Publicado: (2010)

Comparison of the risk of heart failure in psoriasis patients using anti‐TNF α inhibitors and ustekinumab
por: Han, Ju Hee, et al.
Publicado: (2022)

7-Nitroindazole and its rapidly emerging role in opioid pain management and withdrawal
por: Kapoor, Shailendra
Publicado: (2012)

Paradoxical Flare of Psoriasis after Ustekinumab Therapy
por: Lee, Ho Yeol, et al.
Publicado: (2017)

Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis
por: Lynch, Maeve, et al.
Publicado: (2017)

sMICA and its emerging role as a prognostic and diagnostic indicator in systemic malignancies besides hepatocellular carcinoma
por: Kapoor, Shailendra
Publicado: (2013)

Curcumin and Its Emerging Role in Pain Modulation and Pain Management
por: Kapoor, Shailendra
Publicado: (2012)

Prominin-1 and Its Role in Tumor Progression and Assessment of Clinical Prognosis in Systemic Malignancies
por: Kapoor, Shailendra
Publicado: (2013)

Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab
por: van der Schoot, Lara S., et al.
Publicado: (2022)

Potential role of ustekinumab in the treatment of chronic plaque psoriasis
por: Mercuri, Santo Raffaele, et al.
Publicado: (2010)

Genome-Wide Association Study of Ustekinumab Response in Psoriasis
por: Connell, William T., et al.
Publicado: (2022)

Toenail Psoriasis during Ustekinumab Therapy: Results and Limitations
por: Yang, Seungkeol, et al.
Publicado: (2021)

Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancies
por: Kapoor, Shailendra
Publicado: (2012)

Comment on “Berberine and Its Emerging Benefits in Psychiatric Conditions Especially Alzheimer's Disease”
por: Kapoor, Shailendra
Publicado: (2013)

Emerging new therapeutic applications of capecitabine as a first-line chemotherapeutic agent in the management of advanced carcinomas other than colorectal carcinoma
por: Kapoor, Shailendra
Publicado: (2012)

Rare Complications of Kikuchi's Disease: Beyond Pain Control
por: Kapoor, Shailendra
Publicado: (2012)

Emerging Role of Geminin as a Prognostic Marker in Systemic Malignancies
por: Kapoor, Shailendra
Publicado: (2012)

The use of ustekinumab in a patient with severe psoriasis and positive HBV serology()
por: Steglich, Raquel Bissacotti, et al.
Publicado: (2014)

Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab
por: Garcia-Valladares, Ignacio, et al.
Publicado: (2011)

Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease
por: Hermanns-Lê, Trinh, et al.
Publicado: (2012)

Influence of ustekinumab on body weight of patients with psoriasis: an initial report
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2014)

Ustekinumab-induced amelioration of both palmoplantar psoriasis and psoriatic glossitis
por: Tonini, Annalisa, et al.
Publicado: (2019)

Listeria Meningitis in a Patient With Plaque Psoriasis on Ustekinumab Therapy
por: Roy, Moni, et al.
Publicado: (2022)

Vitamin C and Its Emerging Role in Pain Management: Beneficial Effects in Pain Conditions Besides Post Herpetic Neuralgia
por: Kapoor, Shailendra
Publicado: (2012)

Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
por: Elkady, Amal, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q733oani6489ric763r82kq9ht